Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2008
10/30/2008WO2008106980A3 Recombinant antibodies for treatment of respiratory syncytial virus infections
10/30/2008WO2008103471A3 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease
10/30/2008WO2008098139A3 Axl tyrosine kinase inhibitors and methods of making and using the same
10/30/2008WO2008097817A3 Multivariable antigens complexed with targeting humanized monoclonal antibody
10/30/2008WO2008078177A3 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence
10/30/2008WO2008074840A3 Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
10/30/2008WO2008074329A3 Modulation of activity of proneurotrophins
10/30/2008WO2008073312A3 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof
10/30/2008WO2008070593A3 Variant target binding agents and uses thereof
10/30/2008WO2008063898A3 Methods of treating idiopathic thrombocytopenia purpura using a gm-csf antagonist
10/30/2008WO2008057709A3 Sol-gel materials for cellular modulation
10/30/2008WO2008054724A3 Monoclonal antibodies against osteopontin
10/30/2008WO2008031056A3 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
10/30/2008WO2008009004A3 Reagents for the detection of protein phosphorylation in signaling pathways
10/30/2008WO2007140434A3 Immune-derived moieties reactive against lysophosphatidic acid
10/30/2008WO2007124143A3 Methods for high-throughput screening of cell lines
10/30/2008WO2007109307A3 Antibodies directed to angiopoietin-like protein 4 and uses thereof
10/30/2008WO2007089871A3 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
10/30/2008WO2007015886A8 Phosphorylated protein markers of gleevec-resistant chronic myelogenous leukemia
10/30/2008WO2004112717A3 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof
10/30/2008WO2004087735A3 Proteolytic and covalent antibodies
10/30/2008US20080271167 for treatment of viral infection and nervous systtem disorders
10/30/2008US20080269467 Anti-IL-17 Antibodies
10/30/2008US20080269466 Modified Antibody Fragments
10/30/2008US20080269465 Tumor necrosis factor specific immunoglobulin for use in prevention and treatment of rheumatoid arthritis, ulcerative colitis, multiple sclerosis and crohn's disease
10/30/2008US20080269464 Compositions and methods for modulating lymphocte activity
10/30/2008US20080269157 Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080269115 Immunogenic Sars Domain
10/30/2008US20080268536 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
10/30/2008US20080268519 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
10/30/2008US20080268518 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses
10/30/2008US20080268499 Nucleotide sequences coding hormone recptors for use in identifying modulaors of insect propagation; biological pest control; insecticides
10/30/2008US20080268480 Using b-cell activating factor (BAFF) concentration as evaluative tool in diagnosing liver, autoimmune, liver and blood disorder
10/30/2008US20080268477 Advanced glycation endproduct (AGE); 3,4-dideoxyglucosone-3-ene (3,4-DGE); immunization
10/30/2008US20080268474 Prion protein ligands and methods of use
10/30/2008US20080268468 Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
10/30/2008US20080268462 Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits
10/30/2008US20080268461 Method of Measuring Cholesterol in Remnant-Like Lipoproteins
10/30/2008US20080268459 Immunoglobulin for use in diagnosis and treatment of cell proliferative disorders; antitumor agents; immunodiagnostics
10/30/2008US20080268453 Types of lymphoma and method for prognosis thereof
10/30/2008US20080267988 Myelin specific IgE unencumbered by corresponding blocking antibodies as a causative factor in multiple sclerosis
10/30/2008US20080267986 Using beta amyloid antigenic fragment to produce vaccine for prevention and treatment of autoimmune, nervous system and diabetic disorders
10/30/2008US20080267984 Using low density lipoprotein receptor specific immunoglobulin to increase receptor expression on antigen presenting cells; immunotherapy; treating infection, autoimmune, graft vs host and allergic disorders
10/30/2008US20080267982 Generating E7 oncoprotein specific immunoglobulin for use as evaluative tool in diagnosing urogenital cell proliferative, brain and prion disorders
10/30/2008US20080267981 Treating neoplastic diseases with antibody-cytotoxin conjugate (duocarmycins); integrins; 3-[5-(1-(3-aminopropyl)indole-2-carbonyl)aminoindole-2-carbonyl]-1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benz[e]indole
10/30/2008US20080267980 Complement Receptor 2 Targeted Complement Modulators
10/30/2008US20080267979 Heparan sulfate proteoglycan specific immunoglobulin for use in treatment and prevention of liver cancers
10/30/2008US20080267976 Optimized Anti-Cd30 Antibodies
10/30/2008US20080267975 Using lymphocyte profiles comprising aberrant transmembrane receptor tyrosine kinase (Mer) expression as evaluative tool in screening for blood clotting and/or cell proliferative disorders
10/30/2008US20080267974 Tumor necrosis factor specific immunoglobulin for use in diagnosis and treatment of autoimmune diseases
10/30/2008US20080267973 Diagnosis and Treatment of Siglec-6 Associated Diseases
10/30/2008US20080267971 Antibodies Directed to Angiopoietin-2 and Uses Thereof
10/30/2008US20080267968 Using cocktail comprising endothelial growth factor specific immunoglobulin and chemotherapeutic agent to treat and/or prevent cervical cancer
10/30/2008US20080267967 Modulation of cd200 receptors
10/30/2008US20080267966 Polypeptides from Non-Typeable Haemophilus Influenzae
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267959 Interleukin-13 specific immunoglobulin for treatment of asthma, skin, vision, inflammatory, cell proliferative, fibrotic and allergic disorders
10/30/2008US20080267958 Lymphatic endothelial glycoprotein for use as tool in identifying modulators for prevention and treatment of inflammation and cell proliferative disorders
10/30/2008US20080267953 Anti-perp recombinant antibody
10/30/2008US20080267910 Nucleotide sequences coding interleukin-21/22 for use in identifying modulators for prevention and treatment of viral infection and cell proliferative disorders
10/30/2008US20080267872 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
10/30/2008US20080267871 Cardioinhibitory/ Antihypertensive Novel Endogenous Physiologically Active Peptide
10/30/2008US20080267865 Targeting of Erb Antigens
10/30/2008US20080267863 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer
10/30/2008CA2685185A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
10/30/2008CA2685182A1 Osteopontin functional epitopes, monoclonal antibody against the epitopes and uses thereof
10/30/2008CA2685123A1 Methods and compositions for treating and monitoring treatment of il-13-associated disorders
10/30/2008CA2685056A1 Negative immunomodulation of immune responses by erp5
10/30/2008CA2684707A1 Mo-1, a gene associated with morbid obesity
10/30/2008CA2684626A1 Penta-specific antibodies binding il-8, gro-alpha, gro-beta, gro-gamma and ena-78
10/30/2008CA2684492A1 Antibodies against il-25
10/30/2008CA2684330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
10/30/2008CA2684323A1 Prevention and treatment of cerebral amyloid angiopathy
10/30/2008CA2683079A1 Novel fully human anti-vap-1 monoclonal antibodies
10/30/2008CA2682605A1 Single chain fc, methods of making and methods of treatment
10/30/2008CA2682390A1 Pdgfr.beta.-specific inhibitors
10/30/2008CA2682282A1 Use of an mmp28 inhibitor for increasing myelination
10/30/2008CA2665881A1 Methods for providing prophylactic surface treatment for fluid processing systems and components thereof
10/29/2008EP1985706A2 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/29/2008EP1985703A2 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
10/29/2008EP1985701A2 Genes differentially expressed in breast cancer
10/29/2008EP1985634A1 Modulators of p-selectin glycoprotein ligand 1
10/29/2008EP1985633A1 Kit of parts for the treatment of cancer or infectious diseases
10/29/2008EP1985632A2 Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation
10/29/2008EP1985630A2 T1R taste receptors and genes encoding same
10/29/2008EP1985626A1 P. gingivalis antigenic composition
10/29/2008EP1985625A2 Synthetic peptide constructs for the diagnosis and treatment of periodontitus associated with porphyromonas gingivalis
10/29/2008EP1985306A2 TRX1 antibody and uses therefor
10/29/2008EP1984736A2 Cd86 and cd80 receptor competition assays
10/29/2008EP1984522A2 Methods of increasing lymphatic function
10/29/2008EP1984405A2 Influenza antigens, vaccine compositions, and related methods
10/29/2008EP1984404A2 Methods and compositions for targeting relt
10/29/2008EP1984403A2 Antibodies to ox-2/cd200 and uses thereof
10/29/2008EP1984402A2 Antibodies directed to her-3 and uses thereof
10/29/2008EP1984401A2 Il-17 antagonistic antibodies fpr treating cancer
10/29/2008EP1984400A2 Regulators of nfat
1 ... 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 ... 1494